Clinical Trial Update: Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer [NA]

View source ↗

Summary

Exploratory neoadjuvant study evaluating sunitinib malate as part of therapy for breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: Indiana University | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2014-08-12